The Complex Roles of Mechanistic Target of Rapamycin in Adipocytes and Beyond

[1]  Y. Bossé,et al.  mTORC1 is Required for Brown Adipose Tissue Recruitment and Metabolic Adaptation to Cold , 2016, Scientific Reports.

[2]  Mi-Sung Kim,et al.  ChREBP regulates fructose-induced glucose production independently of insulin signaling. , 2016, The Journal of clinical investigation.

[3]  Scott A. Brown,et al.  mTORC1 and mTORC2 Kinase Signaling and Glucose Metabolism Drive Follicular Helper T Cell Differentiation. , 2016, Immunity.

[4]  S. A. Arriola Apelo,et al.  mTORC2 Puts Its Shoulder to Krebs' Wheel. , 2016, Molecular cell.

[5]  J. Rabinowitz,et al.  mTORC2 Responds to Glutamine Catabolite Levels to Modulate the Hexosamine Biosynthesis Enzyme GFAT1. , 2016, Molecular cell.

[6]  C. Proud,et al.  mTOR inhibitors in cancer therapy , 2016, F1000Research.

[7]  Ryan Berry,et al.  The Adipose Tissue Microenvironment Regulates Depot-Specific Adipogenesis in Obesity. , 2016, Cell metabolism.

[8]  S. Kuang,et al.  Adipocyte-specific deletion of mTOR inhibits adipose tissue development and causes insulin resistance in mice , 2016, Diabetologia.

[9]  R. Loewith,et al.  TORC2 Structure and Function. , 2016, Trends in biochemical sciences.

[10]  M. Birnbaum,et al.  Lack of AKT in adipocytes causes severe lipodystrophy , 2016, Molecular metabolism.

[11]  Pascale G. Charest,et al.  The small GTPases Ras and Rap1 bind to and control TORC2 activity , 2016, Scientific Reports.

[12]  C. Kahn,et al.  Lipodystrophy Due to Adipose Tissue–Specific Insulin Receptor Knockout Results in Progressive NAFLD , 2016, Diabetes.

[13]  Kalyani V. P. Guntur,et al.  Activation of mTORC1 is essential for β-adrenergic stimulation of adipose browning. , 2016, The Journal of clinical investigation.

[14]  A. Kowaltowski,et al.  Constitutive adipocyte mTORC1 activation enhances mitochondrial activity and reduces visceral adiposity in mice. , 2016, Biochimica et biophysica acta.

[15]  Christian M. Metallo,et al.  Adipose tissue mTORC2 regulates ChREBP-driven de novo lipogenesis and hepatic glucose metabolism , 2016, Nature Communications.

[16]  Elisa de Stanchina,et al.  Overcoming mTOR Resistance Mutations with a New Generation mTOR Inhibitor , 2016, Nature.

[17]  D. Guertin,et al.  Raptor/mTORC1 loss in adipocytes causes progressive lipodystrophy and fatty liver disease , 2016, Molecular metabolism.

[18]  L. Toral-Barza,et al.  mTOR complex-2 stimulates acetyl-CoA and de novo lipogenesis through ATP citrate lyase in HER2/PIK3CA-hyperactive breast cancer , 2016, Oncotarget.

[19]  Gregory A. Wyant,et al.  The CASTOR Proteins Are Arginine Sensors for the mTORC1 Pathway , 2016, Cell.

[20]  J. Asara,et al.  mTORC1 induces purine synthesis through control of the mitochondrial tetrahydrofolate cycle , 2016, Science.

[21]  Dudley Lamming,et al.  Rapamycin Blocks Induction of the Thermogenic Program in White Adipose Tissue , 2016, Diabetes.

[22]  M. Hall,et al.  mTORC2 sustains thermogenesis via Akt‐induced glucose uptake and glycolysis in brown adipose tissue , 2016, EMBO molecular medicine.

[23]  D. Sabatini,et al.  Sestrin2 is a leucine sensor for the mTORC1 pathway , 2016, Science.

[24]  Michael N. Hall,et al.  Architecture of human mTOR complex 1 , 2016, Science.

[25]  Christian M. Metallo,et al.  Branched chain amino acid catabolism fuels adipocyte differentiation and lipogenesis , 2015, Nature chemical biology.

[26]  M. Hall,et al.  Multiple amino acid sensing inputs to mTORC1 , 2015, Cell Research.

[27]  R. Çetinkaya,et al.  New-Onset Diabetes Mellitus Associated with Sirolimus Use in Renal Transplant Recipients. , 2015, The Eurasian journal of medicine.

[28]  E. Arias.  Lysosomal mTORC2/PHLPP1/Akt axis: a new point of control of chaperone-mediated autophagy , 2015, Oncotarget.

[29]  Ruth Nussinov,et al.  Defining the Domain Arrangement of the Mammalian Target of Rapamycin Complex Component Rictor Protein , 2015, J. Comput. Biol..

[30]  David E James,et al.  A Positive Feedback Loop between Akt and mTORC2 via SIN1 Phosphorylation. , 2015, Cell reports.

[31]  Webster K. Cavenee,et al.  Glucose-dependent acetylation of Rictor promotes targeted cancer therapy resistance , 2015, Proceedings of the National Academy of Sciences.

[32]  R. Aebersold,et al.  Molecular Basis of the Rapamycin Insensitivity of Target Of Rapamycin Complex 2. , 2015, Molecular cell.

[33]  B. Spiegelman,et al.  Brown and Beige Fat: Molecular Parts of a Thermogenic Machine , 2015, Diabetes.

[34]  C. Behrends,et al.  Amino Acid-Dependent mTORC1 Regulation by the Lysosomal Membrane Protein SLC38A9 , 2015, Molecular and Cellular Biology.

[35]  G. Prasad,et al.  New-onset diabetes mellitus after kidney transplantation: Current status and future directions. , 2015, World journal of diabetes.

[36]  K. Kandror,et al.  4E-BPs Control Fat Storage by Regulating the Expression of Egr1 and ATGL* , 2015, The Journal of Biological Chemistry.

[37]  Klaus Scheffler,et al.  Selective Insulin Resistance in Homeostatic and Cognitive Control Brain Areas in Overweight and Obese Adults , 2015, Diabetes Care.

[38]  D. Guertin,et al.  Highly Selective In Vivo Labeling of Subcutaneous White Adipocyte Precursors with Prx1-Cre , 2015, Stem cell reports.

[39]  M. Reitman,et al.  Integration of body temperature into the analysis of energy expenditure in the mouse , 2015, Molecular metabolism.

[40]  D. James,et al.  Selective Insulin Resistance in Adipocytes* , 2015, The Journal of Biological Chemistry.

[41]  K. Petersen,et al.  Hepatic Acetyl CoA Links Adipose Tissue Inflammation to Hepatic Insulin Resistance and Type 2 Diabetes , 2015, Cell.

[42]  K. Shiozaki,et al.  Fission yeast Ryh1 GTPase activates TOR Complex 2 in response to glucose , 2015, Cell cycle.

[43]  Gregory A. Wyant,et al.  Lysosomal amino acid transporter SLC38A9 signals arginine sufficiency to mTORC1 , 2015, Science.

[44]  K. Guan,et al.  Differential regulation of mTORC1 by leucine and glutamine , 2015, Science.

[45]  S. O’Rahilly,et al.  Seipin oligomers can interact directly with AGPAT2 and lipin 1, physically scaffolding critical regulators of adipogenesis , 2015, Molecular metabolism.

[46]  G. Superti-Furga,et al.  SLC38A9 is a component of the lysosomal amino acid-sensing machinery that controls mTORC1 , 2014, Nature.

[47]  N. Leitinger,et al.  Catecholamine-induced lipolysis causes mTOR complex dissociation and inhibits glucose uptake in adipocytes , 2014, Proceedings of the National Academy of Sciences.

[48]  J. Chambard,et al.  Glucose uptake in brown fat cells is dependent on mTOR complex 2–promoted GLUT1 translocation , 2014, The Journal of cell biology.

[49]  C. Cloninger,et al.  mTORC2 modulates feedback regulation of p38 MAPK activity via DUSP10/MKP5 to confer differential responses to PP242 in glioblastoma , 2014, Genes & cancer.

[50]  Jinming Yu,et al.  Epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of central nerve system metastases from non-small cell lung cancer. , 2014, Cancer letters.

[51]  D. Guertin,et al.  Rictor/mTORC2 loss in the Myf5 lineage reprograms brown fat metabolism and protects mice against obesity and metabolic disease. , 2014, Cell reports.

[52]  E. Neumann-Haefelin,et al.  mTORC2-SGK-1 acts in two environmentally responsive pathways with opposing effects on longevity , 2014, Aging cell.

[53]  K. Guan,et al.  Rag GTPases are cardioprotective by regulating lysosomal function , 2014, Nature Communications.

[54]  D. Sabatini,et al.  Regulation of mTORC1 by amino acids. , 2014, Trends in cell biology.

[55]  E. Rosen,et al.  Characterization of Cre recombinase models for the study of adipose tissue , 2014, Adipocyte.

[56]  O. McGuinness,et al.  Pathway-selective Insulin Resistance and Metabolic Disease: The Importance of Nutrient Flux* , 2014, The Journal of Biological Chemistry.

[57]  Feng Liu,et al.  Grb10 promotes lipolysis and thermogenesis by phosphorylation-dependent feedback inhibition of mTORC1. , 2014, Cell metabolism.

[58]  D. Guertin,et al.  Adipocytes arise from multiple lineages that are heterogeneously and dynamically distributed , 2014, Nature Communications.

[59]  David M. Sabatini,et al.  Myeloid-Specific Rictor Deletion Induces M1 Macrophage Polarization and Potentiates In Vivo Pro-Inflammatory Response to Lipopolysaccharide , 2014, PloS one.

[60]  J. Vance.  MAM (mitochondria-associated membranes) in mammalian cells: lipids and beyond. , 2014, Biochimica et biophysica acta.

[61]  Dudley Lamming,et al.  RagA, but not RagB, is essential for embryonic development and adult mice. , 2014, Developmental cell.

[62]  Sang Gyun Kim,et al.  Rapamycin: one drug, many effects. , 2014, Cell metabolism.

[63]  M. E. Ràfols,et al.  Adipose tissue: cell heterogeneity and functional diversity. , 2014, Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion.

[64]  Montserrat Esteve Ràfols.  Adipose tissue: Cell heterogeneity and functional diversity , 2014 .

[65]  Feng Liu,et al.  mTOR complex 2 controls glycolytic metabolism in glioblastoma through FoxO acetylation and upregulation of c-Myc. , 2013, Cell metabolism.

[66]  M. Lazar,et al.  Lipoatrophy and severe metabolic disturbance in mice with fat-specific deletion of PPARγ , 2013, Proceedings of the National Academy of Sciences.

[67]  Steven P. Gygi,et al.  Sin1 phosphorylation impairs mTORC2 complex integrity and inhibits downstream Akt signaling to suppress tumorigenesis , 2013, Nature Cell Biology.

[68]  P. Seale,et al.  Brown and beige fat: development, function and therapeutic potential , 2013, Nature Medicine.

[69]  D. Sabatini,et al.  The folliculin tumor suppressor is a GAP for the RagC/D GTPases that signal amino acid levels to mTORC1. , 2013, Molecular cell.

[70]  S. Ferguson,et al.  Recruitment of folliculin to lysosomes supports the amino acid–dependent activation of Rag GTPases , 2013, The Journal of cell biology.

[71]  Mee-Sup Yoon,et al.  Mechanistic target of rapamycin controls homeostasis of adipogenesis , 2013, Journal of Lipid Research.

[72]  F. Zwartkruis,et al.  Rheb and Rags come together at the lysosome to activate mTORC1. , 2013, Biochemical Society transactions.

[73]  Kinyui A. Lo,et al.  Turning WAT into BAT: a review on regulators controlling the browning of white adipocytes , 2013, Bioscience reports.

[74]  M. Hall,et al.  mTOR complex 2-Akt signaling at mitochondria-associated endoplasmic reticulum membranes (MAM) regulates mitochondrial physiology , 2013, Proceedings of the National Academy of Sciences.

[75]  David E. James,et al.  Dynamic Adipocyte Phosphoproteome Reveals that Akt Directly Regulates mTORC2 , 2013, Cell metabolism.

[76]  N. Pavletich,et al.  mTOR kinase structure, mechanism and regulation by the rapamycin-binding domain , 2013, Nature.

[77]  P. Meikle,et al.  Distinct patterns of tissue-specific lipid accumulation during the induction of insulin resistance in mice by high-fat feeding , 2013, Diabetologia.

[78]  U. Knippschild,et al.  De novo lipogenesis in human fat and liver is linked to ChREBP-β and metabolic health , 2013, Nature Communications.

[79]  Ryan Berry,et al.  Characterization of the adipocyte cellular lineage in vivo , 2013, Nature Cell Biology.

[80]  Yuanyuan Wu,et al.  Adipose tissue heterogeneity: implication of depot differences in adipose tissue for obesity complications. , 2013, Molecular aspects of medicine.

[81]  J. Montani,et al.  A Role for Adipose Tissue De Novo Lipogenesis in Glucose Homeostasis During Catch-up Growth , 2013, Diabetes.

[82]  M. Czaja,et al.  Regulation of lipid stores and metabolism by lipophagy , 2012, Cell Death and Differentiation.

[83]  Guoyao Wu,et al.  Regulation of brown adipose tissue development and white fat reduction by L-arginine , 2012, Current opinion in clinical nutrition and metabolic care.

[84]  E. Gottlieb,et al.  Glutaminolysis activates Rag-mTORC1 signaling. , 2012, Molecular cell.

[85]  D. Sabatini,et al.  DEPTOR cell-autonomously promotes adipogenesis, and its expression is associated with obesity. , 2012, Cell metabolism.

[86]  A. Soukas,et al.  Identification of Akt-independent Regulation of Hepatic Lipogenesis by Mammalian Target of Rapamycin (mTOR) Complex 2* , 2012, The Journal of Biological Chemistry.

[87]  D. Ouwens,et al.  Role of PRAS40 in Akt and mTOR signaling in health and disease. , 2012, American journal of physiology. Endocrinology and metabolism.

[88]  T. Walther,et al.  The Transcription Factor TFEB Links mTORC1 Signaling to Transcriptional Control of Lysosome Homeostasis , 2012, Science Signaling.

[89]  C. Karp.  Unstressing intemperate models: how cold stress undermines mouse modeling , 2012, The Journal of experimental medicine.

[90]  B. Evers,et al.  mTOR inhibitors in cancer therapy. , 2012, Cancer letters.

[91]  Nicholas T. Ingolia,et al.  The translational landscape of mTOR signalling steers cancer initiation and metastasis , 2012, Nature.

[92]  M. Hall,et al.  Hepatic mTORC2 activates glycolysis and lipogenesis through Akt, glucokinase, and SREBP1c. , 2012, Cell metabolism.

[93]  M. Simon,et al.  PRR5L degradation promotes MTORC2-mediated PKCδ phosphorylation and cell migration downstream of Gα12 , 2012, Nature Cell Biology.

[94]  M. Blüher,et al.  A novel ChREBP isoform in adipose tissue regulates systemic glucose metabolism , 2012, Nature.

[95]  B. Edgar,et al.  LST8 Regulates Cell Growth via Target-of-Rapamycin Complex 2 (TORC2) , 2012, Molecular and Cellular Biology.

[96]  D. Sabatini,et al.  mTOR Signaling in Growth Control and Disease , 2012, Cell.

[97]  C. Klausmeier,et al.  Ecological Context Influences Epidemic Size and Parasite-Driven Evolution , 2012, Science.

[98]  Dudley Lamming,et al.  Rapamycin-Induced Insulin Resistance Is Mediated by mTORC2 Loss and Uncoupled from Longevity , 2012, Science.

[99]  R. Coleman,et al.  Glycerolipid signals alter mTOR complex 2 (mTORC2) to diminish insulin signaling , 2012, Proceedings of the National Academy of Sciences.

[100]  Guoyao Wu,et al.  Arginine nutrition and fetal brown adipose tissue development in nutrient-restricted sheep , 2011, Amino Acids.

[101]  Raymond Vanholder,et al.  New-Onset Diabetes After Renal Transplantation , 2011, Diabetes Care.

[102]  M. Mayo,et al.  Multiple Site Acetylation of Rictor Stimulates Mammalian Target of Rapamycin Complex 2 (mTORC2)-dependent Phosphorylation of Akt Protein* , 2011, The Journal of Biological Chemistry.

[103]  T. Kishimoto,et al.  Turn motif phosphorylation negatively regulates activation loop phosphorylation in Akt , 2011, Oncogene.

[104]  D. Sarbassov,et al.  Endoplasmic reticulum is a main localization site of mTORC2. , 2011, Biochemical and biophysical research communications.

[105]  Sarat Chandarlapaty,et al.  mTOR kinase inhibition causes feedback-dependent biphasic regulation of AKT signaling. , 2011, Cancer discovery.

[106]  Anne E Carpenter,et al.  mTOR Complex 1 Regulates Lipin 1 Localization to Control the SREBP Pathway , 2011, Cell.

[107]  S. Gygi,et al.  Phosphoproteomic Analysis Identifies Grb10 as an mTORC1 Substrate That Negatively Regulates Insulin Signaling , 2011, Science.

[108]  D. Accili,et al.  Hyperinsulinemia leads to uncoupled insulin regulation of the GLUT4 glucose transporter and the FoxO1 transcription factor , 2011, Proceedings of the National Academy of Sciences.

[109]  I. Hers,et al.  mTORC2 Protein-mediated Protein Kinase B (Akt) Serine 473 Phosphorylation Is Not Required for Akt1 Activity in Human Platelets* , 2011, The Journal of Biological Chemistry.

[110]  D. Alessi,et al.  Protor-1 is required for efficient mTORC2-mediated activation of SGK1 in the kidney. , 2011, The Biochemical journal.

[111]  L. Cantley,et al.  Rac1 regulates the activity of mTORC1 and mTORC2 and controls cellular size. , 2011, Molecular cell.

[112]  D. Sabatini,et al.  The mTOR-Regulated Phosphoproteome Reveals a Mechanism of mTORC1-Mediated Inhibition of Growth Factor Signaling , 2011, Science.

[113]  V. Zinzalla,et al.  Activation of mTORC2 by Association with the Ribosome , 2011, Cell.

[114]  B. Viollet,et al.  AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1 , 2011, Nature Cell Biology.

[115]  Jan Nedergaard,et al.  Nonshivering thermogenesis and its adequate measurement in metabolic studies , 2011, Journal of Experimental Biology.

[116]  Mingming Jia,et al.  COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer , 2010, Nucleic Acids Res..

[117]  Philippe P Roux,et al.  mTORC2 can associate with ribosomes to promote cotranslational phosphorylation and stability of nascent Akt polypeptide , 2010, The EMBO journal.

[118]  D. Schatz,et al.  Sin1-mTORC2 suppresses rag and il7r gene expression through Akt2 in B cells. , 2010, Molecular cell.

[119]  D. Sabatini,et al.  Structure of the human mTOR complex I and its implications for rapamycin inhibition. , 2010, Molecular cell.

[120]  N. Sonenberg,et al.  S6K1 plays a critical role in early adipocyte differentiation. , 2010, Developmental cell.

[121]  D. Sabatini,et al.  Ragulator-Rag Complex Targets mTORC1 to the Lysosomal Surface and Is Necessary for Its Activation by Amino Acids , 2010, Cell.

[122]  M. Magnuson,et al.  Fat Cell–Specific Ablation of Rictor in Mice Impairs Insulin-Regulated Fat Cell and Whole-Body Glucose and Lipid Metabolism , 2010, Diabetes.

[123]  K. Shokat,et al.  Targeting the cancer kinome through polypharmacology , 2010, Nature Reviews Cancer.

[124]  B. Kahn,et al.  Adipose Tissue Branched Chain Amino Acid (BCAA) Metabolism Modulates Circulating BCAA Levels* , 2010, The Journal of Biological Chemistry.

[125]  Lisa L. Smith,et al.  AZD8055 is a potent, selective, and orally bioavailable ATP-competitive mammalian target of rapamycin kinase inhibitor with in vitro and in vivo antitumor activity. , 2010, Cancer research.

[126]  A. Grefhorst,et al.  Fenofibrate Simultaneously Induces Hepatic Fatty Acid Oxidation, Synthesis, and Elongation in Mice* , 2009, The Journal of Biological Chemistry.

[127]  Cristina T Fonseca,et al.  Novel mutations of the BSCL2 and AGPAT2 genes in 10 families with Berardinelli–Seip congenital generalized lipodystrophy syndrome , 2009, Clinical endocrinology.

[128]  D. Sabatini,et al.  Rapamycin inhibits mTORC1, but not completely , 2009, Autophagy.

[129]  M. Lazar,et al.  Brown Fat in Humans: Turning up the Heat on Obesity , 2009, Diabetes.

[130]  J. Auwerx,et al.  mTOR complex 2 in adipose tissue negatively controls whole-body growth , 2009, Proceedings of the National Academy of Sciences.

[131]  She Chen,et al.  ULK1·ATG13·FIP200 Complex Mediates mTOR Signaling and Is Essential for Autophagy* , 2009, Journal of Biological Chemistry.

[132]  D. Sabatini,et al.  DEPTOR Is an mTOR Inhibitor Frequently Overexpressed in Multiple Myeloma Cells and Required for Their Survival , 2009, Cell.

[133]  Svati H Shah,et al.  A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. , 2009, Cell metabolism.

[134]  D. A. Foster,et al.  Targeting mTOR with rapamycin: One dose does not fit all , 2009, Cell cycle.

[135]  J. Guan,et al.  Nutrient-dependent mTORC1 association with the ULK1-Atg13-FIP200 complex required for autophagy. , 2009, Molecular biology of the cell.

[136]  T. Walther,et al.  TORC2 plasma membrane localization is essential for cell viability and restricted to a distinct domain. , 2009, Molecular biology of the cell.

[137]  Gerard Manning,et al.  TORC-specific phosphorylation of mammalian target of rapamycin (mTOR): phospho-Ser2481 is a marker for intact mTOR signaling complex 2. , 2009, Cancer research.

[138]  B. Cannon,et al.  UCP1 ablation induces obesity and abolishes diet-induced thermogenesis in mice exempt from thermal stress by living at thermoneutrality. , 2009, Cell metabolism.

[139]  D. Sabatini,et al.  Rag proteins regulate amino-acid-induced mTORC1 signalling. , 2009, Biochemical Society transactions.

[140]  D. Alessi,et al.  mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1). , 2008, The Biochemical journal.

[141]  E. Casanova,et al.  Skeletal muscle-specific ablation of raptor, but not of rictor, causes metabolic changes and results in muscle dystrophy. , 2008, Cell metabolism.

[142]  J. Auwerx,et al.  Adipose-specific knockout of raptor results in lean mice with enhanced mitochondrial respiration. , 2008, Cell metabolism.

[143]  M. Simons,et al.  Syndecan-4 regulates subcellular localization of mTOR Complex2 and Akt activation in a PKCalpha-dependent manner in endothelial cells. , 2008, Molecular cell.

[144]  S. Watkins,et al.  Identification of a Lipokine, a Lipid Hormone Linking Adipose Tissue to Systemic Metabolism , 2008, Cell.

[145]  A. Newton,et al.  The mammalian target of rapamycin complex 2 controls folding and stability of Akt and protein kinase C , 2008, The EMBO journal.

[146]  K. Inoki,et al.  Essential function of TORC2 in PKC and Akt turn motif phosphorylation, maturation and signalling , 2008, The EMBO journal.

[147]  T. P. Neufeld,et al.  Regulation of TORC1 by Rag GTPases in nutrient response , 2008, Nature Cell Biology.

[148]  A. Webster,et al.  Sirolimus is associated with new-onset diabetes in kidney transplant recipients. , 2008, Journal of the American Society of Nephrology : JASN.

[149]  M. Capecchi,et al.  Two cell lineages, myf5 and myf5-independent, participate in mouse skeletal myogenesis. , 2008, Developmental cell.

[150]  J. Goldstein,et al.  Selective versus total insulin resistance: a pathogenic paradox. , 2008, Cell metabolism.

[151]  Pengxiang She,et al.  Obesity-related elevations in plasma leucine are associated with alterations in enzymes involved in branched-chain amino acid metabolism. , 2007, American journal of physiology. Endocrinology and metabolism.

[152]  John C. Lawrence,et al.  Muscle-Specific Deletion of Rictor Impairs Insulin-Stimulated Glucose Transport and Enhances Basal Glycogen Synthase Activity , 2007, Molecular and Cellular Biology.

[153]  D. Alessi,et al.  Identification of Protor as a novel Rictor-binding component of mTOR complex-2. , 2007, The Biochemical journal.

[154]  Lewis C. Cantley,et al.  AKT/PKB Signaling: Navigating Downstream , 2007, Cell.

[155]  Nicole Cloonan,et al.  Human Sin1 contains Ras-binding and pleckstrin homology domains and suppresses Ras signalling. , 2007, Cellular signalling.

[156]  S. Carr,et al.  PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase. , 2007, Molecular cell.

[157]  Timothy J. Griffin,et al.  Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40 , 2007, Nature Cell Biology.

[158]  D. Guertin,et al.  Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1. , 2006, Developmental cell.

[159]  J. Qin,et al.  SIN1/MIP1 Maintains rictor-mTOR Complex Integrity and Regulates Akt Phosphorylation and Substrate Specificity , 2006, Cell.

[160]  Jacob D. Jaffe,et al.  mSin1 Is Necessary for Akt/PKB Phosphorylation, and Its Isoforms Define Three Distinct mTORC2s , 2006, Current Biology.

[161]  D. Sabatini,et al.  Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. , 2006, Molecular cell.

[162]  M. Hall,et al.  TOR Signaling in Growth and Metabolism , 2006, Cell.

[163]  Gordon B Mills,et al.  mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt. , 2006, Cancer research.

[164]  S. Kane,et al.  Full intracellular retention of GLUT4 requires AS160 Rab GTPase activating protein. , 2005, Cell metabolism.

[165]  R. Loewith,et al.  Molecular Organization of Target of Rapamycin Complex 2* , 2005, Journal of Biological Chemistry.

[166]  J. Harper,et al.  Control of lipid metabolism by phosphorylation-dependent degradation of the SREBP family of transcription factors by SCF(Fbw7). , 2005, Cell metabolism.

[167]  L. Pinna,et al.  Protein kinase CK2 phosphorylates and upregulates Akt/PKB , 2005, Cell Death and Differentiation.

[168]  R. Loewith,et al.  Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive , 2004, Nature Cell Biology.

[169]  D. Guertin,et al.  Rictor, a Novel Binding Partner of mTOR, Defines a Rapamycin-Insensitive and Raptor-Independent Pathway that Regulates the Cytoskeleton , 2004, Current Biology.

[170]  D. Accili,et al.  FoxOs at the Crossroads of Cellular Metabolism, Differentiation, and Transformation , 2004, Cell.

[171]  D. V. van Aalten,et al.  PDK1, the master regulator of AGC kinase signal transduction. , 2004, Seminars in cell & developmental biology.

[172]  Jan Nedergaard,et al.  Brown adipose tissue: function and physiological significance. , 2004, Physiological reviews.

[173]  J. Blenis,et al.  Tuberous Sclerosis Complex Gene Products, Tuberin and Hamartin, Control mTOR Signaling by Acting as a GTPase-Activating Protein Complex toward Rheb , 2003, Current Biology.

[174]  K. Inoki,et al.  Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. , 2003, Genes & development.

[175]  S. Sehgal.  Sirolimus: its discovery, biological properties, and mechanism of action. , 2003, Transplantation proceedings.

[176]  John M Asara,et al.  Insulin-stimulated Phosphorylation of a Rab GTPase-activating Protein Regulates GLUT4 Translocation* , 2003, The Journal of Biological Chemistry.

[177]  K. Klingel,et al.  Impaired renal Na(+) retention in the sgk1-knockout mouse. , 2002, The Journal of clinical investigation.

[178]  J. Crespo,et al.  Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control. , 2002, Molecular cell.

[179]  M. Sajan,et al.  Knockout of PKC Enhances Insulin Signaling Through PI3K , 2002 .

[180]  J. Lawrence,et al.  Insulin-stimulated phosphorylation of lipin mediated by the mammalian target of rapamycin , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[181]  A. Bowcock,et al.  AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34 , 2002, Nature Genetics.

[182]  B. Geoerger,et al.  Antitumor activity of the rapamycin analog CCI-779 in human primitive neuroectodermal tumor/medulloblastoma models as single agent and in combination chemotherapy. , 2001, Cancer research.

[183]  M. Primig,et al.  Myf5 is a novel early axonal marker in the mouse brain and is subjected to post-transcriptional regulation in neurons. , 2000, Development.

[184]  R. Weigel,et al.  Identification of a human Akt3 (protein kinase B gamma) which contains the regulatory serine phosphorylation site. , 1999, Biochemical and biophysical research communications.

[185]  S. Snyder,et al.  RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[186]  Christine C. Hudson,et al.  Phosphorylation of the translational repressor PHAS-I by the mammalian target of rapamycin. , 1997, Science.

[187]  P. Cohen,et al.  Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Bα , 1997, Current Biology.

[188]  J. Woodgett,et al.  Molecular cloning and characterisation of a novel putative protein-serine kinase related to the cAMP-dependent and protein kinase C families. , 1991, European journal of biochemistry.

[189]  B. Hemmings,et al.  Molecular cloning and identification of a serine/threonine protein kinase of the second-messenger subfamily. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[190]  M. Glotzer,et al.  Mitochondrial uncoupling protein from mouse brown fat. Molecular cloning, genetic mapping, and mRNA expression. , 1985, The Journal of biological chemistry.

[191]  D. Nicholls,et al.  Thermogenic mechanisms in brown fat. , 1984, Physiological reviews.